ESR1 and ductal breast carcinoma in situ: In addition, an analysis of ER concordance in our progressor cohort showed that hormone positive DCIS most often progressed to hormone positive IBC (94%), whereas hormone negative DCIS usually progressed to hormone positive IBC (78%, Fig. 5D).